Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-108838
Filing Date
2023-10-12
Accepted
2023-10-12 16:43:57
Documents
6
Effectiveness Date
2023-10-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2328250d1_s8.htm S-8 60581
2 EXHIBIT 4.8 tm2328250d1_ex4-8.htm EX-4.8 119562
3 EXHIBIT 5.1 tm2328250d1_ex5-1.htm EX-5.1 42872
4 EXHIBIT 23.2 tm2328250d1_ex23-2.htm EX-23.2 3272
5 EX-FILING FEES tm2328250d1_ex-filingfees.htm EX-FILING FEES 14095
6 GRAPHIC image_001.jpg GRAPHIC 4192
  Complete submission text file 0001104659-23-108838.txt   247478
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: S-8 | Act: 33 | File No.: 333-274954 | Film No.: 231323163
SIC: 2834 Pharmaceutical Preparations